Academic Journal
Q2CNS and Neurological Disorders – Drug Targets
About CNS and Neurological Disorders – Drug Targets
CNS and Neurological Disorders - Drug Targets is a scholarly journal published by Bentham Science Publishers. SCImago 2025 lists it in Q2, with an SJR of 0.789 and H-index of 105.
Coverage: 2006-2026. Research categories: Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2).
Source-backed journal facts
Topics in published research
Alzheimer's disease research and treatments; Tryptophan and brain disorders; Cholinesterase and Neurodegenerative Diseases; Neuroscience and Neuropharmacology Research; Neuroinflammation and Neurodegeneration Mechanisms; Parkinson's Disease Mechanisms and Treatments.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Molecular Footprints of Diabetic Peripheral Neuropathy: Investigating Transcriptional Modulation of Sphingolipid Metabolism, Myelin-specific Genes and Neurotrophic Factors Under Elevated Glucose and Harnessing Therapeutic Potential of DHA and ALA
Suman Samaddar, Moqbel Ali Moqbel Redhwan, Mohan Muttanahally Eraiah
2026-09-30 · DOI: 10.2174/0118715273459828260925063553Neuroinflammation and Autophagy in Neurodegeneration: Cellular Mechanisms and Therapeutic Strategies
Anushka Verma, Swatantra Kumar Singh Kushwaha, Neelottama Kushwaha, Sayantan Dutta et al.
2026-09-29 · DOI: 10.2174/0118715273459017260922073618Resveratrol's Therapeutic Role in Sepsis-Associated Encephalopathy
Shuoyan Dong, Qian Cui, Lei Zong, Yixin Xue et al.
2026-09-22 · DOI: 10.2174/0118715273502075260910113533Nanoparticle-mediated Therapeutic Inventions against Glioblastoma: A Narrative Review on Current Perspectives
Bida Joshua John, Dauda Maibasha, Ratnakar Shukla, Adil Husain et al.
2026-09-17 · DOI: 10.2174/0118715273453180260908055829Cholinesterase Inhibitors in Alzheimer's Disease: Medicinal Chemistry, Mechanistic Insights, and Emerging Multitarget Strategies
Anuradha Mehra, Rahul Sharma, Amit Mittal
2026-09-17 · DOI: 10.2174/0118715273435274260907101735Exploring the Potential of Quinoline-Containing Pyrazoline Derivatives as Antidepressant Agents: In Vivo and In Silico Studies
Bharti Sharma, Chahat, Pawan Kumar, Ajit Kumar et al.
2026-09-09 · DOI: 10.2174/0118715273408493260904055147Effect of N-Acetylcysteine in Reducing Postoperative Cognitive Dysfunction after Anaesthesia in Elderly Patients Undergoing Day Surgery: A Randomized Controlled Study
Jaishree Mohanbabu, Abishek Manogaran, Sri Harish Kumar Srinivasan, Anandan Prabakar Rohith et al.
2026-09-08 · DOI: 10.2174/0118715273485933260821105708The Gut-Brain Axis: Exploring the Role of Gut Microbiota in Alzheimer’s Disease Pathogenesis and Therapeutics
Javeria Fatima, Yasir Hasan Siddique
2026-09-07 · DOI: 10.2174/0118715273460507260827112721Circadian Rhythm Disruption in Alzheimer’s Disease: Mechanistic Insights, Diagnostic Implications, and Emerging Chronotherapeutic Strategies: A Narrative Review
Jasleen Kaur, Ritu Kainth, Roopal Mittal, Arshpreet Kaur et al.
2026-09-04 · DOI: 10.2174/0118715273425623260210180623Cortisol Dysregulation as a Major Factor in the Development of Neurodegenerative Diseases, Drug Targets and Therapeutic Prospects: A Comprehensive Review
Reza Hooshyari Ardakani, Mohadeseh Dashtaki, Seyed-Mahdi Mohamadi-Zarch, Seyyed Majid Bagheri et al.
2026-08-24 · DOI: 10.2174/0118715273466502260813092749Nano-Magnetism for Precision Neuroscience: Biohybrid Magnetoelectric Nanocarriers as Next-Generation Neural Drug Delivery Platforms
Shikha Baghel Chauhan, Aniket Bhardwaj, Chirag Jain, Indu Singh et al.
2026-08-24 · DOI: 10.2174/0118715273397455251030094458Combining Lycopene, Quercetin, and Poloxamer 188 Therapy Reduces Learning and Memory Deficits in the 3-nitropropionic Acid-induced Rat Model of Huntington's Disease
Arti A. Bhimanwar, Swati P. Barangule, Hemlata M. Nimje, Suchita P. Dhamane et al.
2026-08-21 · DOI: 10.2174/0118715273450391260807100448Tanshinone IIA Improves Depression-like Behaviors in Ovariectomized Mice
Wen Lin, Jiayan Li, Yi Deng, Li Mao et al.
2026-08-06 · DOI: 10.2174/0118715273492076260803052821Decreased Anti-inflammatory IL-2 and IL-10 and Increased Mononuclear Cell Tissue Factor Correlate with Stroke Severity: Do Anti-inflammatory Cytokines Modulate Thrombosis?
Kiana Mohammadian, Tahereh Kalantari, Rasoul Ebrahimi, Nahid Nasiri et al.
2026-08 · DOI: 10.2174/0118715273434957260202115619Research Prospects for mTOR in Neuroinflammation: A Bibliometric Analysis
Lu Liang, Meijuan Wang, Zhaoyang Liu, Shuchao Wang et al.
2026-08 · DOI: 10.2174/0118715273398806251024072412Breaking Through Barriers: The Transformative Potential of Nanomedicine in Overcoming Drug Delivery Challenges for Psychiatric Disorders
Virendra Kumar Yadav, Shazia Tahira, Renuka Jyothi, Pankaj Kumar et al.
2026-08 · DOI: 10.2174/0118715273384176250929130818Natural Products Targeting Alzheimer’s Disease via NF-κB Pathway: A Review
Faizul Hasan, Kothinti Thippamma, Vijender Kumar, Aizhamal Baiseitova et al.
2026-08 · DOI: 10.2174/0118715273397045250922054643A Novel Polymorphic Form of Sodium Benzoate (Ω-NaBen): Improved Solubility, Stability, Central Nervous System Effects, and Antipsychotic Activities via D-Amino Acid Regulation
Wei-Hua Chang, Yi-An Lai, Hsing-Chun Tsai, Yi-Wen Mao et al.
2026-08 · DOI: 10.2174/0118715273359634250626102333Integrating Synthesis, Pharmacological Activity, and Molecular Modeling to Explore 1,2,4-Triazine Fused Thiazolidin-4-one Derivatives as GABA A Receptor Modulators
Hariram Singh, Devender Pathak, Shikha Parmar
2026-08 · DOI: 10.2174/0118715273368721251029081903Decoding the Gut-Brain Axis in Alzheimer’s Disease: Emerging Perspectives
Vijay Singh, Amisha Yadav, Tahreen Taj, Anas Islam et al.
2026-08 · DOI: 10.2174/0118715273390442250805174841Reviews
Community Reviews
Version History
October 2, 2026 at 8:58 pm
October 2, 2026